The Risk of Atrial Fibrillation and Previous Ischemic Stroke in Cognitive Decline

Tunde Pal1, Dragos-Florin Baba2, Zoltan Preg3,4

  • 1Department of Internal Medicine V, George Emil Palade University of Medicine Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.

PubMed

Insights

Cognitive decline is linked to cardiovascular conditions like atrial fibrillation and stroke. Specific cognitive tests, including MOCA and MMSE, can help identify patients at risk for these diseases.

Area of Science:

  • Neurology
  • Cardiology
  • Geriatrics

Background:

  • Cognitive decline (CD) is a growing concern, often associated with various underlying health conditions.
  • Understanding the relationship between cognitive function and cardiovascular diseases is crucial for early detection and management.

Purpose of the Study:

  • To investigate the inverse relationship between cognitive decline and documented cardiovascular conditions such as atrial fibrillation (AFib), ischemic stroke, heart failure, peripheral artery disease, and diabetes mellitus.
  • To evaluate the diagnostic utility of standard cognitive tests in identifying these conditions.

Main Methods:

  • A retrospective cross-sectional study involving 469 patients who underwent cognitive evaluation using the Montreal Cognitive Assessment (MOCA), Mini-Mental State Examination (MMSE), and General Practitioner Assessment of Cognition (GPCOG).
  • Standard and optimal cut-off values derived from receiver operating characteristic curves were used to assess associations.

Main Results:

  • Lower MOCA scores (<26) were associated with AFib (OR: 1.83), and optimal cut-offs (<23) with ischemic stroke (OR: 2.64).
  • Lower MMSE scores (<28) correlated with ischemic stroke (OR: 3.07), AFib (OR: 1.65), and peripheral artery disease (OR: 2.72).
  • GPCOG scores (<8) indicated associations with ischemic stroke (OR: 2.18) and heart failure (OR: 1.49).

Conclusions:

  • Cognitive assessments, particularly MOCA and MMSE, demonstrate significant utility in identifying patients with documented AFib.
  • Specific cognitive test results, including lower MOCA scores and higher MMSE/GPCOG scores than standard thresholds, are risk factors for previous ischemic stroke.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
73
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
109
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
114
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.2K